IL16 and COVID-19: Taken together, the IgM glycosylation profile closely correlates with COVID-19 severity on clinical and serological parameters and the cytokines IL-16 and IL-18 may play a role in controlling downstream glycosyltransferase expression in plasma blasts during COVID-19.